oxalate ( µ mol / gfw )

3
0 20 40 60 0 2 4 6 8 0 2 4 6 8 10 12 0 2 4 6 8 Oxalate (µmol/gFW) Itaconate (µmol/gFW) r=- 0.702** Citrate (µmol/gFW) r=0.389 0.00 0.02 0.04 0.06 0.08 0.10 0.12 0 2 4 6 8 Isocitrate (µmol/gFW) 0.0 0.5 1.0 1.5 2.0 0 2 4 6 8 Ascorbate (µmol/gFW) r=0.052 r=0.19 5 New Leaves 10 mM Itaconate 1 weeks 10 mM Itaconate 2 weeks 10 mM Itaconate 3 weeks Itaconate (µmol/gFW) Supplementary Data 1 Miyagi et al.

Upload: oswald

Post on 04-Feb-2016

103 views

Category:

Documents


0 download

DESCRIPTION

Supplementary Data 1 Miyagi et al. New Leaves. r =-0.702**. Isocitrate ( µmol/gFW ). Oxalate ( µ mol / gFW ). r =0.052. Ascorbate ( µmol/gFW ). Citrate ( µmol/gFW ). r =0.195. r =0.389. Itaconate ( µmol/gFW ). Itaconate ( µmol/gFW ). 10 mM Itaconate 1 weeks. 10 mM Itaconate 2 weeks. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Oxalate ( µ mol / gFW )

0

20

40

60

0 2 4 6 8

02468

1012

0 2 4 6 8Oxa

late

(µm

ol/g

FW)

Itaconate (µmol/gFW)

r=-0.702**

Citr

ate

(µm

ol/g

FW)

r=0.389

0.000.020.040.060.080.100.12

0 2 4 6 8Is

ocitr

ate

(µm

ol/g

FW)

0.0

0.5

1.0

1.5

2.0

0 2 4 6 8

Asc

orba

te (µ

mol

/gFW

)

r=0.052

r=0.195

New Leaves

10 mM Itaconate 1 weeks 10 mM Itaconate 2 weeks 10 mM Itaconate 3 weeks

Itaconate (µmol/gFW)

Supplementary Data 1 Miyagi et al.

Page 2: Oxalate ( µ mol / gFW )

-2

-1

0

1

2

3

-2 -1 0 1 2 3

PC 1 (35.1 %)

PC 2 (18.1 %)

-0.06

-0.04

-0.02

0.00

0.02

0.04

0.06

-0.08-0.06-0.04-0.020.000.020.040.060.080.10

Stems

-2

-1

0

1

2

3

-3 -2 -1 0 1 2 3

-2

-1

0

1

2

3

-2 -1 0 1 2 3-0.15

-0.10

-0.05

0.00

0.05

0.10

0.15

0.20

: Organic acid: Amino acid: Phosphorylated

PC 2 (18.1 %)

PC 1 (35.1 %)

Isoc

itrat

eO

rnith

ine

Asc

orba

teR

uBP

Cou

mar

ate

6PG

Aco

nita

teG

lyFB

PA

spS

hiki

mat

eP

yruv

ate

Suc

cina

teC

itrat

eC

ysTr

pS

erA

laD

HA

PG

6PR

u5P

R5P

Glu

Cin

nam

ate

Citr

ullin

eG

AB

ATy

rP

heLe

uLy

sV

alIleA

snA

rgTh

rM

etP

roH

is2O

GP

EP

3PG

AO

xala

teG

1PG

lnM

alat

eFu

mar

ate

Isoc

itrat

eO

rnith

ine

Asc

orba

teR

uBP

Cou

mar

ate

6PG

Aco

nita

teG

lyFB

PA

spS

hiki

mat

eP

yruv

ate

Suc

cina

teC

itrat

eC

ysTr

pS

erA

laD

HA

PG

6PR

u5P

R5P

Glu

Cin

nam

ate

Citr

ullin

eG

AB

ATy

rP

heLe

uLy

sV

alIleA

snA

rgTh

rM

etP

roH

is2O

GP

EP

3PG

AO

xala

teG

1PG

lnM

alat

eFu

mar

ate

Isoc

itrat

eO

rnith

ine

Asc

orba

teR

uBP

Cou

mar

ate

6PG

Aco

nita

teG

lyFB

PA

spS

hiki

mat

eP

yruv

ate

Suc

cina

teC

itrat

eC

ysTr

pS

erA

laD

HA

PG

6PR

u5P

R5P

Glu

Cin

nam

ate

Citr

ullin

eG

AB

ATy

rP

heLe

uLy

sV

alIleA

snA

rgTh

rM

etP

roH

is2O

GP

EP

3PG

AO

xala

teG

1PG

lnM

alat

eFu

mar

ate

PC 1 loadings

PC 2 loadings

PC 3 loadingsPC 3 (10.4%)

PC 3 (10.4%)

Control 0 week Control 1 week Control 2 weeks Control 3 weeks10 mM Itaconate 0 week 10 mM Itaconate 1 weeks 10 mM Itaconate 2 weeks 10 mM Itaconate 3 weeks

a

b

c

d

e

f

Supplementary Data 2 Miyagi et al.

compound

Page 3: Oxalate ( µ mol / gFW )

0

1

2

3

0 1 2 3 4

0

1

2

3

4

0 1 2 3 40

20

40

60

0 1 2 3 4

0.00

0.01

0.02

0.03

0.04

0 1 2 3 4

Oxa

late

(µm

ol/g

FW)

Itaconate (µmol/gFW)

r=-0.113

Citr

ate

(µm

ol/g

FW)

r=-0.058

Isoc

itrat

e (µ

mol

/gFW

)A

scor

bate

(µm

ol/g

FW)

r=-0.488*

r=-0.396

Stems

10 mM Itaconate 0 week 10 mM Itaconate 1 weeks 10 mM Itaconate 2 weeks 10 mM Itaconate 3 weeks

Itaconate (µmol/gFW)

Supplementary Data 3 Miyagi et al.